Skip to main content
Journal of Clinical Medicine logoLink to Journal of Clinical Medicine
. 2023 Sep 28;12(19):6263. doi: 10.3390/jcm12196263

Outcome Analysis of Speed Gate Cannulation during Standard Infrarenal Endovascular Aneurysm Repair

Domenico Mirabella 1, Salvatore Evola 2, Ettore Dinoto 1,*, Carlo Setacci 3, David Pakeliani 4, Francesco Setacci 5,6, Paolo Annicchiarico 1, Felice Pecoraro 1,7
Editor: Konstantinos Donas
PMCID: PMC10573247  PMID: 37834906

Abstract

Background: Endovascular aortic repair (EVAR) is generally performed with bi/trimodular stent-grafts requiring retrograde contralateral gate cannulation (CGC). In the case of tricky CGC, an increased EVAR procedural time and radiation exposure have been reported. Herein, we compare the outcomes of conventional CGC and CGC using the speed gate cannulation (SGC) technique in standard EVAR for a propensity-matched cohort. Methods: A total of 371 patients were retrospectively analyzed. Inclusion criteria were fulfilled in 172 patients who underwent propensity score matching. Primary outcomes included operative time, CGC time, mean contrast medium, fluoroscopy time, and CGC fluoroscopy time. Results: After matching, 78 patients were included in each group (SGC vs. standard). Primary outcomes registered a significant reduction in CGC time (4 [1–6] vs. 8 [6–14] min; p = 0.001) and fluoroscopy time (12 [9–16] vs. 17 [12–25] min). Conclusions: In this preliminary experiment, the use of SGC was feasible with no significant registered postoperative complications. A significant reduction in contrast medium usage, radiation exposure, and CGC time was observed with the use of SGC. SGC is a simple adjunctive technique, and its use should be considered in standard EVAR, especially in emergency scenarios, where time is of the essence.

Keywords: speed gate cannulation, contralateral limb, gate, cannulation, EVAR, abdominal aortic aneurysm

1. Introduction

The endovascular aortic repair (EVAR) of abdominal aortic aneurysms (AAAs) with bi- or tri-modular stent-grafts involves multiple steps, including contralateral gate cannulation (CGC) [1]. Standard CGC is carried out in a retrograde fashion through contralateral femoral access. Different AAA anatomic variables have been associated with difficult standard CGC and increased EVAR procedural times, radiation exposure, and endovascular material costs for a bailout [2]. To facilitate CGC, we usually resort to the speed-gate cannulation technique (SGC), a tool that reduces the time of this step by allowing us to open the gate near to the guide wire coming from the contralateral access. Herein, we compare the outcomes of conventional CGC and CGC using the SGC technique in standard EVAR for a propensity-matched cohort.

2. Materials and Methods

From February 2017 to December 2022, patients treated with standard EVAR using bi- or tri-modular stent-grafts to address AAAs were retrospectively analyzed. Of the 371 patients analyzed, conventional CGC was used in 151 (40.7%) patients and SGC in 220 (59.3%) patients. Since 2015, SGC has been employed at our institution as a standard step for all patients undergoing EVAR for AAAs.

A total of 199 patients were excluded for being treated in a non-elective setting, with aortouniliac EVAR, EVAR relining, complex EVAR, or EVAR after a previous surgical intervention. The remaining 172 patients were considered eligible for inclusion (first procedure for AAA in an elective setting without the need for additional treatments beyond implantation of the aortic prosthesis); 83 (48.5%) patients were treated with a conventional CGC and 89 (51.5%) using SGC. Patients were matched using the propensity score method to obtain 2 homogeneous groups of patients treated using conventional CGC and SGC.

All patients included in the study gave informed consent for the procedure itself, anonymous data collection, and analysis. According to the Institutional Review Board, the retrospective and anonymized nature of the study did not require medical ethics committee approval. The study was performed in agreement with the Declaration of Helsinki and followed the STROBE guidelines for reporting observational studies [3].

Primary outcomes included operative time, CGC time, mean contrast medium, fluoroscopy time, dose-area product (DAP), and CGC fluoroscopy time. Secondary outcomes were perioperative mortality and morbidity, endoleak incidence, number of iliac stent-grafts, survival, and freedom from reintervention. Technical success was defined as endograft deployment in the intended position and no angiographic type I or III endoleaks, or limb occlusion within 24 h after the EVAR.

Before the procedure, every patient was studied with CTA. The same imaging was employed for follow-up, including a CTA performed at 2 and 12 months and duplex ultrasound at 6 months. In patients with renal function impairment, a standard computed tomography (CT) and contrast-enhanced ultrasound replaced CTA after the same time interval.

SGC Technique. Until contraindicated and according to the instruction for use, a bilateral percutaneous approach using a 6 Fr Prostyle vascular closure device (Abbott Vascular, Redwood City, CA, USA) was preferred. After preclosing, a 10 Fr introducer sheath was inserted over the access guidewire bilaterally. A 5 Fr Multipurpose catheter was introduced to facilitate guidewire exchange to a 0.035-inch stiff wire (Backup Meier or Amplatz, Boston Scientific, Natick, MA, USA).

The contralateral 10 Fr sheath on the intended main body introduction side was exchanged for a 30 cm 12–18 Fr Dryseal introducer sheath (W. L. Gore & Associates, Medical Products Division, Flagstaff, AZ, USA) over the stiff wire and advanced into the aorta at the level of the lowest renal artery. A short dilator was employed to place it parallel to the stiff wire; an additional 0.035-inch standard J-tip guidewire was applied through the Dryseal introducer. A 5 Fr pigtail angiographic catheter was advanced over the standard J-tip guidewire into the aorta above the level of the renal arteries (Figure 1).

Figure 1.

Figure 1

(A) Short dilator and parallel 0.035-inch standard J-tip guide-wire through the Dryseal introducer. (B) A 5 Fr pigtail angiographic catheter advancement.

Through the main access, the main body was advanced and positioned at the level of the renal arteries. At this point, the positioned main body was rotated to orientate the distal markers of the contralateral gate in the direction of the route of the contralateral wires. The aim of the orientation is to allow the contralateral gate to open as close as possible to the contralateral wireless route (Figure 2).

Figure 2.

Figure 2

(A) Main body introduction before orientation towards the contralateral supported sheath route. (B) Main body rotation to orientate the distal markers of the contralateral gate in the direction of the route of the contralateral wires.

Then, the Dryseal introducer was lowered just below the markers of the contralateral gate; an aortography was performed from the placed 5 Fr pigtail, to visualize the renal arteries; and the stent-graft main body was deployed in a crossed limb “ballerina” or standard configuration depending on the previous orientation. Such steps aim to obtain a supported sheath as close as possible to the contralateral gate opening, to speed up the CGC (Figure 3A). A standard J-tip guidewire is inserted into the 5 Fr pigtail to lower it just below the opening of the contralateral gate at the same level as the 16 Fr Dryseal introducer tip. The CGC begins using the same 5 Fr pigtail and the standard J-tip guidewire; both the J-tip guidewire and 5 Fr pigtail can be exchanged to facilitate CGC (Figure 3B).

Figure 3.

Figure 3

(A) Contralateral supported sheath lowering below the contralateral gate radiopaque markers and main body deployment in ballerina configuration. (B) Contralateral gate cannulation with buddy wire through the contralateral supported sheath.

After CGC, the 5 Fr pigtail was advanced over the J-tip guidewire up to the ascending aorta, the coaxial stiff wire was withdrawn and exchanged with the J-tip guidewire into the 5 Fr pigtail. Subsequent EVAR steps were as standard, according to the device instructions for use.

Statistical Analysis. Propensity score matching was performed to obtain 2 homogeneous groups in terms of age, sex, and associated comorbidities (hypertension, ever smoker, chronic obstructive pulmonary disease, cerebrovascular disease, peripheral arterial disease [PAD], diabetes mellitus [DM], coronary disease, lipid disorder), previous cardiac interventions, preoperative GFR < 60 mL/min, left ventricle ejection fraction < 50%, preoperative New York Heart Association (NYHA) classification, American Society of Anesthesiologists (ASA) classification, type of anesthesia, aneurysm behavior (maximal diameter, neck length, neck angle, neck diameter, common iliac artery (CIA) involvement, and aortic carrefour angulation on coronal axis), and operation details (stent-graft fabric, number of components, and “ballerina” configuration).

Categorical variables were reported as absolute number and frequency (%) and compared using the chi-squared or Fisher’s exact test. Continuous data were reported as the median [interquartile range] and compared using the Mann–Whitney U-test. These statistical methods were used in both unmatched and matched groups.

Kaplan–Meier curves were used to estimate survival and freedom from reinterventions in patients undergoing standard contralateral gate cannulation and speed gate cannulation. A bivariate test was used to assess the relationship significance for correlation analysis. Statistical significance was considered to be p < 0.05. For Kaplan–Meier, a standard error exceeding 10% was reported. Statistical analysis was performed using SPSS 22.0 (SPSS Inc., Chicago, IL, USA).

3. Results

After propensity score analysis on 172 patients, 78 patients in the conventional CGC group and SGC group were included for a total of 156 patients (Figure 4).

Figure 4.

Figure 4

Population flow chart.

The baseline characteristics of both matched and unmatched groups are reported in Table 1. Before matching, a significant difference was observed for hypertension, PAD, lipid disorders, preoperative NYHA classification, and aneurysm behavior. After matching, non-significant differences were observed in both standard CGC and SGC groups (Table 1).

Table 1.

Baseline patient characteristics of unmatched and matched cohort.

Unmatched Cohort Matched Cohort
Variables SGC (89) STD (83) p SGC (78) STD (78) SE Diff p
Age, y, (SD) 78 [±8] 81 [±9] 0.16 78 [±8] 81 [±9] −6.4 0.21
Male gender, n (%) 63 (70.8) 67 (80.7) 0.94 62 (79.5) 63 (80.8) 0.12 1
Associated comorbidities
  Hypertension, n (%) 81 (91) 67 (80.7) <0.001 65 (83.3) 59 (75.6) 0.07 0.66
  Ever smoker, n (%) 48 (53.9) 49 (59) 0.9 47 (60.2) 46 (59) 0.11 0.9
  COPD, n (%) 11 (12.3) 15 (18.1) 0.6 10 (12.8) 10 (12.8) 0.12 0.77
  CVD, n (%) 8 (9) 7 (8.4) 0.4 6 (7.7) 6 (7.7) 0.14 0.75
  PAD, n (%) 11 (12.3) 17 (20.5) <0.001 10 (12.8) 11 (14.1) 0.12 0.74
  Diabetes, n (%) 41 (46.1) 48 (57.8) 0.2 35 (44.9) 27 (34.6) 0.13 0.55
  Lipid Disorder, n (%) 63 (70.8) 55 (66.3) <0.001 57 (73.1) 54 (69.2) 0.15 0.42
  CAD, n (%) 44 (49.4) 42 (50.6) 0.3 35 (44.9) 41 (52.6) 0.11 0.58
Previous CI, n (%) 21 (23.6) 27 (32.5) 0.5 17 (21.8) 18 (23.1) 0.05 0.66
Preop GFR < 60 mL/min, n (%) 10 (11.2) 12 (14.4) 0.4 9 (11.5) 9 (11.5) 0.11 0.71
LVEF < 50%, n (%) 13 (14.6) 15 (18.1) 0.4 12 (15.4) 13 (16.7) 0.15 0.75
Preoperative NYHA classification
  I, n (%) 69 (77.5) 57 (68.7) 0.5 60 (76.9) 56 (71.8) 0.09 0.89
  II, n (%) 12 (13.5) 16 (19.3) 0.6 11 (14.1) 14 (18) 0.11 0.71
  III, n (%) 5 (5.6) 6 (7.2) <0.001 4 (5.1) 5 (6.4) 0.13 0.77
  IV, n (%) 3 (3.4) 4 (4.8) 0.3 3 (3.8) 3 (3.8) 0.08 0.91
ASA classification
  I, n (%) 0 0 1 0 0 - 1
  II, n (%) 0 0 1 0 0 - 1
  III, n (%) 63 (70.8) 61 (73.5) 0.4 59 (75.7) 58 (74.4) 0.13 0.66
  IV, n (%) 26 (29.2) 22 (26.5) 0.5 19 (24.3) 20 (25.6) 0.11 0.74
Aneurysm behavior
  MATD, mm [IQR] 64 [55–71] 66 [55–77] 0.42 65 [55–69] 65 [55–70] 3.7 0.35
  Neck length, mm [IQR] 13 [10–19] 15 [11–22] 0.12 14 [10–19] 15 [11–21] 6.8 0.18
  Neck angle, ° [IQR] 43 [25–55] 34 [22–41] 0.05 38 [23–40] 39 [24–40] 4.8 0.37
  Neck diameter, mm [IQR] 26 [22–29] 24 [20–27] 0.6 24 [21–28] 24 [20–28] 7.2 0.36
Right CIA involvement, n (%) 17 (19.1) 13 (15.7) 0.73 15 (19.2) 12 (15.4) 0.11 0.42
Left CIA involvement, n (%) 7 (7.9) 9 (10.8) 0.65 6 (7.7) 8 (10.2) 0.12 0.39
Fusiform Shape, n (%) 63 (70.8) 59 (71.1) 0.8 58 (74.4) 55 (70.5) 0.3 0.71

SGC: speed gate cannulation; STD: standard cannulation; SE Diff: standard error difference; y: years; IQR: interquartile range; n: numbers; COPD: chronic obstructive pulmonary disease; CVD: cerebrovascular disease; PAD: peripheral arterial disease; CAD: coronary artery disease; CI: cardiac interventions; Preop: preoperative; GFR: glomerular filtration rate; LVEF: left ventricular ejection fraction; NYHA classification: New York Heart Association classification; ASA: American Society of Anesthesiologists; MATD: maximal aneurysm transverse diameter; CIA: common iliac artery.

In the conventional CGC group, the mean follow-up was 38.77 ± 21 (median: 36; IQR: 24–60) months; in the SGC group the mean follow-up was 37.46 ± 20 (median: 36; IQR: 24–60) months, p = 0.17.

After matching, primary outcomes registered no significant differences in overall operative time (73 [67–85] vs. 77 [74–86] min; p = 0.07) between the two groups. In the SGC group, a significant reduction was reported for CGC time (4 [1–6] vs. 8 [6–14] min; p = 0.001); mean contrast medium (61 [50–72] vs. 77 [71–92] mL; p = 0.03); fluoroscopy time (12 [9–16] vs. 17 [12–25] min; p = 0.001); DAP (15 [9–21] vs. 26 [16–34] G*cm2; p = 0.002); and CGC fluoroscopy time (45 [26–65] vs. 96 [70–133] sec; p = 0.001) (Table 2).

Table 2.

Operative details of the unmatched and matched cohort.

Unmatched Cohort Matched Cohort
Variables SGC (89) STD (83) p SGC (78) STD (78) SE Diff p
Stents graft fabric
  Endurant, n (%) 64 (71.9) 63 (75.9) 0.42 58 (74.4) 59 (75.6) 0.12 1
  Endologix, n (%) 16 (18) 13 (15.7) 0.5 13 (16.7) 12 (15.4) 0.12 1
  Zenith, n (%) 5 (5.6) 4 (4.8) 0.3 4 (5.1) 4 (5.1) 0.15 1
  Excluder, n (%) 4 (4.5) 3 (3.6) 0.3 3 (3.8) 3 (3.8) 0.13 1
Number of components, n [IQR] 2 [1–3] 3 [1–4] 0.16 2 [1–3] 3 [1–3] 1 0.8
“Ballerina” configuration, n (%) 48 (54) 42 (50.6) 0.54 41 (52.6) 41 (52.6) 0.21 0.71
Operative time, min [IQR] 66 [60–75] 79 [68–85] 0.73 73 [67–85] 77 [74–86] 2.1 0.07
CGC time, min [IQR] 3 [1–5] 12 [7–17] <0.001 4 [1–6] 8 [6–14] 1.2 0.001
Mean contrast medium, mL [IQR] 55 [45–72] 81 [77–93] <0.001 61 [50–72] 77 [71–92] 1.3 0.03
Fluoroscopy time, min [IQR] 11 [8–14] 21 [13–23] <0.001 12 [9–16] 17 [12–25] 1.4 0.001
DAP, G*cm2 [IQR] 14 [9–18] 32 [28–36] <0.001 15 [9–21] 26 [16–34] 0.1 <0.001
CGC Fluoroscopy time, sec [IQR] 45 [27] 96 [32] <0.001 45 [26–65] 96 [70–133] 1 0.001

SGC: speed gate cannulation; STD: standard cannulation; SE Diff: standard error difference; DAP: dose area product; CGC contralateral gate cannulation.

The aortic neck angulations on coronal and sagittal axes strongly correlate with cannulation time (p = 0.02) together with AAA sacciform morphology (p = 0.04). A higher cannulation time was associated with a higher neck angulation on coronal and sagittal axes and the presence of a sacciform aneurysm morphology (Table 3).

Table 3.

Pearson correlation.

CGC Time
Aneurysm Behavior Stents Graft Fabric
  MATD Correlation −0.108   Endurant Correlation −0.043
Sig (2-t) 0.48 Sig (2-t) 0.777
  Neck length Correlation −0.139   Endologix Correlation 0.164
Sig (2-t) 0.161 Sig (2-t) 0.281
  Neck angle Correlation −0.347   Zenith Correlation −0.1
Sig (2-t) 0.02 Sig (2-t) 0.513
  Neck diameter Correlation 0.05   Excluder Correlation −0.144
Sig (2-t) 0.744 Sig (2-t) −0.344
Right CIA involvement Correlation 0.1 Number of components Correlation −0.22
Sig (2-t) 0.513 Sig (2-t) 0.146
Left CIA involvement Correlation 0.154 “Ballerina” configuration Correlation −0.093
Sig (2-t) 0.312 Sig (2-t) 0.544
Sacciform Shape Correlation 0.387 Operative time Correlation −0.071
Sig (2-t) 0.04 Sig (2-t) 0.644

The technical success was 100% with no perioperative mortality or type I/III endoleak registered in either group. One perioperative iliac leg occlusion was observed in the SCG group. No differences were observed in the iliac limb components (2 [1,2] vs. 2 [1,2]; p = 0.9). During the follow-up, no aneurysm-related mortality or complications were observed. Survival at 36 months was 97% for the SGC group and 96% for the standard cannulation group (p = 0.678). Freedom from reintervention at 36 months was 93% in both groups (p = 0.834) (Figure 5).

Figure 5.

Figure 5

(A) Survival and (B) freedom from reintervention estimated from 3-year Kaplan–Meier curves for standard contralateral gate cannulation and speed gate cannulation. Standard error does not exceed 10% at 3 years for both survival curves.

4. Discussion

Difficult CGC remains an issue in EVAR procedures to address AAA, even in experienced centers. Difficult CGC has been associated with an increased overall procedure time, CGC time, X-ray exposure, and contrast medium usage [4]. In emergency situations, where time is essential, tools to reduce the time of CGC play an even more important role.

Different anatomic variables have been reported to negatively influence the time required for CGC, including maximal aneurysm diameter, iliac tortuosity, active thrombus-free lumen, and aortic bifurcation angulation [5,6].

In 2019, Pakeliani et al. reported an improved technique for sheath-supported contralateral limb gate cannulation; the only anatomic variable found to correlate significantly with CGC time was the angulation of the aortic bifurcation in the coronal axis [2]. In the present experiment, the anatomic variables correlating significantly with the SGC time were the aortic neck angulations on coronal and sagittal axes and the aneurysm saccular morphology.

Different experiments have reported a correlation between aortic neck angulation and difficult CGC, despite device improvements, and the CGC is still dependent on surgeons’ skills and technical choices [7,8,9,10].

Dang W et al., for a population of 100 consecutive patients treated with EVAR, highlighted the role of angulations on the speed of CGC using a standard cannulation gate technique. They predicted the opening and final position of the contralateral gate to be always near the proximal neck axis [11]. SGS using a supported contralateral sheath aims to provide a closer position to the contralateral gate orifice, to facilitate cannulation. The use of a supporting introducer sheath with an inflatable valve allows simultaneous placement of the coaxial guidewire with no bleeding. In addition, after CGC with SGC, the guide employed to catheterize the CGC is easily exchanged with the supporting stiff wire.

In patients with saccular AAA morphology, we found that the orientation of the contralateral gate was mainly in the direction of the aneurysm sac space, to prevent the gate opening over the aortic wall. Thus, the gate opening orientation did not depend on the best orientation for cannulation with both standard and speed gate cannulation. We argue that this feature was the explanation for the significant correlation between the AAA saccular morphology and higher CGC time.

Also in this series, the CGC time was not influenced by maximum aneurysm diameter and iliac tortuosity. It can be argued that the supported sheath is maintained in the direction of the aortic neck, reducing the possibility of navigating wires and catheters into the aneurysm sac. Moreover, eventual iliac tortuosity is irrelevant due to the introduction of the supported sheath at the level of the aorta.

Additional techniques to facilitate contralateral gate cannulation are available. The crossed-limb technique was reported by Yagihashi K et al. for patients presenting tortuous iliac accesses, to facilitate CGC. However, the crossed limb or “ballerina” configuration does not decrease the time of cannulation [12,13].

The snare technique from contralateral access or the brachial access and consequent trough and trough technique are valid alternatives to achieve technical success but represent a secondary choice due to the more invasive nature and higher risk of dislocation. In addition, higher costs are reported in patients requiring additional maneuvers for anterograde cannulation and subsequent guidewire snaring [4,14,15]

During the follow-up, the SCG was safe with similar results when compared to standard retrograde cannulation in terms of mortality and patency. The SGC allowed a reduction in CGC time, mean contrast medium, fluoroscopy time, radiation exposure, and CGC fluoroscopy time. The SGC was not associated with an increased overall procedural time when compared to standard retrograde gate cannulation.

Overall, the SGC technique facilitates cannulation with the most popular bi/tri-modular stent-grafts available; in our experiments, the SGC allowed us to address several complex AAA anatomies, especially in emergency scenarios.

The first limitation of the present study is related to the retrospective nature and lack of randomized control. Despite the matching propensity process allowing two almost identical groups of treatment in terms of comorbidities and anatomic variables, slight differences between the groups persisted. The limited sample size represents the other limitation of the study’s consistency.

5. Conclusions

In this preliminary experiment, the use of SGC during EVAR was feasible with no significant registered postoperative complications. The SGC was not associated with an increased overall procedure time but with a significant reduction in contrast medium usage, radiation exposure, and CGC time. Deploying the stent-graft main body in a crossed limb configuration when guidewires are crossed at the level of aortic bifurcation is recommended. The SGC is a simple adjunctive technique, and its use should be considered in standard EVAR, especially in emergency scenarios, where time is of the essence.

Author Contributions

Conceptualization, D.M., E.D. and F.P.; methodology, C.S., F.S. and F.P.; software, P.A.; validation, D.M., C.S. and F.P.; formal analysis, E.D. and F.P.; investigation, D.P. and P.A.; resources, S.E. and F.P.; data curation, E.D., D.P. and P.A.; writing—original draft preparation, D.M. and E.D.; writing—review and editing, E.D., C.S. and F.P.; visualization, S.E. and F.P.; supervision, C.S. and F.P.; project administration, F.P. All authors have read and agreed to the published version of the manuscript.

Institutional Review Board Statement

All procedures followed were in accordance with the ethical standards of the Institutional Committee on Human Experimentation and with the Helsinki Declaration. According to the internal review board, the retrospective and anonymized nature of the study did not require medical ethical committee approval.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Conflicts of Interest

The authors declare no conflict of interest.

Funding Statement

This research received no external funding.

Footnotes

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

References

  • 1.Steuer J., Lachat M., Veith F.J., Wanhainen A. Endovascular grafts for abdominal aortic aneurysm. Eur. Heart J. 2016;37:145–151. doi: 10.1093/eurheartj/ehv593. [DOI] [PubMed] [Google Scholar]
  • 2.Pakeliani D., Lachat M., Blohmé L., Kobayashi M., Chaykovska L., Pfammatter T., Puippe G., Veith F.J., Pecoraro F. Improved technique for sheath supported contralateral limb gate cannulation in endovascular abdominal aortic aneurysm repair. Vasa. 2020;49:39–42. doi: 10.1024/0301-1526/a000820. Erratum in Vasa 2021, 50, 158. [DOI] [PubMed] [Google Scholar]
  • 3.von Elm E., Altman D.G., Egger M., Pocock S.J., Gøtzsche P.C., Vandenbroucke J.P. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies. Epidemiology. 2007;18:800–804. doi: 10.1097/EDE.0b013e3181577654. [DOI] [PubMed] [Google Scholar]
  • 4.Titus J.M., Cragg A., Alden P., Alexander J., Manunga J., Stephenson E., Skeik N., Sullivan T. A prospective randomized comparison of contralateral snare versus retrograde gate cannulation in endovascular aneurysm repair. J. Vasc. Surg. 2017;66:387–391. doi: 10.1016/j.jvs.2017.01.038. [DOI] [PubMed] [Google Scholar]
  • 5.Wolf Y.G., Tillich M., Lee W., Rubin G.D., Fogarty T.J., Zarins C.K. Impact of aortoiliac tortuosity on endovascular repair of abdominal aortic aneurysms: Evaluation of 3D computer-based assessment. J. Vasc. Surg. 2001;34:594–599. doi: 10.1067/mva.2001.118586. [DOI] [PubMed] [Google Scholar]
  • 6.Turchino D., Peluso A., Accarino G., Accarino G., De Rosa C., D’Angelo A., Machi P., Mirabella D., Pecoraro F., del Guercio L., et al. A Multicenter Experience of Three Different “Iliac Branched” Stent Grafts for the Treatment of Aorto-Iliac and/or Iliac Aneurysms. Ann. Vasc. Surg. 2023;94:331–340. doi: 10.1016/j.avsg.2023.02.033. [DOI] [PubMed] [Google Scholar]
  • 7.Elahwal M., Nash T., Yusuf S.W. Through and Through Wire Technique for Stabilization of EVAR Main Body during Contralateral Limb Deployment. Ann. Vasc. Surg. 2021;74:515–517. doi: 10.1016/j.avsg.2021.02.018. [DOI] [PubMed] [Google Scholar]
  • 8.Dinoto E., Ferlito F., Mirabella D., Tortomasi G., Bajardi G., Pecoraro F. Type 1A endoleak detachable coil embolization after endovascular aneurysm sealing: Case report. Int. J. Surg. Case Rep. 2021;83:106024. doi: 10.1016/j.ijscr.2021.106024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Pecoraro F., Dinoto E., Mirabella D., Ferlito F., Farina A., Pakeliani D., Lachat M., Urso F., Bajardi G. Endovascular Treatment of Spontaneous and Isolated Infrarenal Acute Aortic Syndrome with Unibody Aortic Stent-Grafts. World J. Surg. 2020;44:4267–4274. doi: 10.1007/s00268-020-05754-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Zeng Q., Huang L., Huang X., Peng M. Endovascular repair of abdominal aortic aneurysm with severely angulated neck and tortuous artery access: Case report and literature review. BMC Surg. 2015;15:20. doi: 10.1186/s12893-015-0005-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Dang W., Kilian M., Peterson M.D., Cinà C. Relationship between access side used to deliver the main body of bifurcated prostheses for endovascular aneurysm repair and speed of cannulation of the contralateral limb. J. Vasc. Surg. 2010;51:33–37.e1. doi: 10.1016/j.jvs.2009.08.003. [DOI] [PubMed] [Google Scholar]
  • 12.Yagihashi K., Nishimaki H., Ogawa Y., Chiba K., Murakami K., Ro D., Ono H., Sakurai Y., Miyairi T., Nakajima Y. Early and Mid-Term Results of Endovascular Aortic Repair Using a Crossed-Limb Technique for Patients with Severely Splayed Iliac Angulation. Ann. Vasc. Dis. 2018;11:91–95. doi: 10.3400/avd.oa.16-00135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Murphy E.H., Arko F.R. Technical Tips for Abdominal Aortic Endografting. Semin. Vasc. Surg. 2008;21:25–30. doi: 10.1053/j.semvascsurg.2007.11.001. [DOI] [PubMed] [Google Scholar]
  • 14.Pecoraro F., Bracale U.M., Farina A., Badalamenti G., Ferlito F., Lachat M., Dinoto E., Asti V., Bajardi G. Single-Center Experience and Preliminary Results of Intravascular Ultrasound in Endovascular Aneurysm Repair. Ann. Vasc. Surg. 2019;56:209–215. doi: 10.1016/j.avsg.2018.09.016. [DOI] [PubMed] [Google Scholar]
  • 15.Mazzaccaro D., Sciarrini M., Nano G. The challenge of gate cannulation during endovascular aortic repair: A hypothesis of simplification. Med. Hypotheses. 2016;94:43–46. doi: 10.1016/j.mehy.2016.06.016. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.


Articles from Journal of Clinical Medicine are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES